Registration for a live webinar on 'Phasing Out Animal Testing: A New Era for Pharmaceutical Innovation' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this free, full length talk
- Economics and Business
-
1. In search of a new paradigm for innovation, free markets, and regulation
- Prof. Daron Acemoglu
-
2. Why economic growth is not the goal
- Ms. Kate Raworth
-
3. Predictions and pandemics: why economies relapse before they recover
- Dr. Stephen Roach
-
4. Capturing AI for business
- Mr. David C. Edelman
-
5. The myth of economic self-reliance: friendshoring, globalization, and the future of trade
- Dr. Edoardo Campanella
-
7. Greentech bubbles and investment in a green revolution
- Dr. William Janeway
-
8. Behavioral economics and business: revolution or reinforcing norms?
- Dr. Antara Haldar
-
9. China’s economic slowdown
- Prof. Yasheng Huang
-
10. A broad view strategy
- Dr. Trudi Lang
-
11. India and the illusion of economic growth
- Prof. Ashoka Mody
-
12. Economic shocks: reflections on behavior, recovery, and the future
- Prof. Emeritus Koichi Hamada
-
14. Productivity and growth: facing the fiscal reality
- Prof. Michael Boskin
-
15. Stablecoins: illusions, claims, and facts
- Prof. Barry Eichengreen
-
16. State capitalism: regulating free markets in a liberal democracy
- Dr. Anna Grosman
-
17. How and why business should embrace effective altruism
- Prof. Peter Singer
-
18. The influence of climate change debate on banking policies
- Sir Howard Davies
-
19. Measuring impact: how and why companies can meet demand for responsibility
- Dr. Lisa Hehenberger
-
20. Minimum wage legislation: effects on levels of employment
- Prof. David Neumark
-
21. Avoiding a deep recession: how governments can plan for financial stability
- Dr. Willem H. Buiter
-
22. Cryptocurrencies: potential, risk, and regulation
- Prof. Anne Sibert
-
23. Inflation: lessons in forecasting and humility
- Prof. Jason Furman
-
25. Deep purpose: why pursue it, and how to implement it
- Prof. Ranjay Gulati
-
26. The green transition: a fundamental reconsideration of land rights and usage
- Dr. Giulio Boccaletti
-
27. Net Positive Manifesto: a business case for changing the world
- Mr. Andrew Winston
-
28. Duopolies in politics and business
- Ms. Katherine Gehl
-
29. The economics of healthcare
- Prof. David Cutler
-
30. Predictive analytics
- Dr. Eric Siegel
- Government and Society
-
34. The future of human progress, economic growth, and rising uncertainty
- Prof. Emeritus Angus Deaton
-
35. The steady-state economy
- Prof. Emeritus Herman Daly
-
36. The US-Asia triangle: government, business, and values
- Prof. Joseph S. Nye Jr.
-
37. AI, governance, and law: how capitalism drives culture and innovation
- Prof. Katharina Pistor
-
38. Confronting neoliberalism: why government is critical to lasting prosperity
- Prof. J. Bradford DeLong
-
39. Cities: living and working in global business centers
- Prof. Edward Glaeser
-
41. Transparency and sustainability: increasing the impact of The World Bank
- Mr. Bertrand Badré
-
42. Moving beyond GDP: modernizing economic indicators
- Prof. Jayati Ghosh
-
43. Regulation, competition, and government Intervention
- Prof. Barry Schwartz
-
45. Globalization in the face of diminishing democracy
- Prof. Grzegorz W. Kolodko
-
46. The UK and EU: Trade, employment, and business after Brexit
- Prof. Anand Menon
-
49. Nuclear energy: a case for fear-defying sustainability
- Prof. Emeritus Joshua S. Goldstein
-
50. Balancing economic prudence and sustainability
- Prof. Emerita Deirdre McCloskey
-
51. Enacting social change on a major scale: the role of business
- Prof. Rebecca Henderson
-
52. The role of economics in setting government policy
- Mr. Sebastian Mallaby
-
53. The European energy crisis
- Dr. Anders Åslund
-
54. US and China: are there any winners in a trade war?
- Mr. Martin Wolf
-
55. Bureaucracy and innovation: the entrepreneurial state
- Prof. Rainer Kattel
-
57. Policy-making: global crises and the role of business
- Dr. Bill Emmott
-
58. Inflation in the shadow of debt: growth, regulations, and reforms
- Dr. John Cochrane
-
59. Why so negative? Impacts and implications of US media coverage
- Prof. Bruce Sacerdote
-
60. Sanctions: war and economic consequences
- Prof. Jeffrey Frankel
-
61. The democratic recession and its impact on business
- Prof. Larry Diamond
-
62. The purpose of public service broadcasting in a democracy
- Prof. Emeritus Patrick Barwise
-
63. Transformation and innovation: cities of the future
- Prof. Carlo Ratti
-
64. MAPS: the business of medical affairs
- Dr. Danie du Plessis
-
65. Translational medicine: the risk of failure in delay and how to reduce it
- Prof. Martin Wehling
- Organisations and Leadership
-
66. Why some leaders thrive and others derail
- Prof. Manfred F. R. Kets de Vries
-
68. Humility and empathy: critical qualities of leadership
- Dr. John Hennessy
-
70. Nurturing the ability to ask impactful questions
- Prof. Robert Langer
-
71. Unity as a lever of Influence: how to create and maintain trust in business
- Dr. Robert Cialdini
-
72. Managing networks in the digital age
- Prof. Linda A. Hill
-
73. Selecting a board leader
- Prof. Michael Useem
-
74. Trust: how and why companies should be good places to come from
- Prof. Sandra J. Sucher
-
75. Where questions come from: developing the capacity to enquire
- Dr. Russ Roberts
-
76. The challenges and impact of investors: what directors should do
- Prof. Michael Useem
-
77. Management of generic drug development: challenges and opportunities
- Mr. Sandeep Patil
-
78. Encouraging corporate learning
- Mr. Brad Samargya
-
79. The strategy spine: how and why you should create one
- Prof. Rita McGrath
-
80. The talent marketplace: what it is, and why large companies need one
- Mr. Donncha Carroll
-
81. Having the best board possible
- Prof. Michael Useem
-
82. Machine learning, AI platforms, and biases
- Mr. Barry Libert
-
83. X-teams: why they succeed and how to nurture them
- Prof. Deborah Ancona
-
84. Online learning: strategies, budgets, and procurements
- Dr. Matt Bluem
-
85. How leaders can get out of the way of organizational change
- Mr. Ron Carucci
-
87. Project management: how to make projects more successful and the role of AI
- Mr. Antonio Nieto-Rodriguez
-
89. How Mumsnet is run
- Ms. Justine Roberts CBE
-
90. Fundamentals of being the trusted advisor
- Mr. Anthony Vardy
-
91. Collaborative innovation and the role of the innovation manager
- Prof. Jill Perry-Smith
-
93. Values that build prosperous businesses
- Dr. Mandeep Rai
-
95. 20-first: building gender balanced businesses
- Ms. Avivah Wittenberg-Cox
-
96. Moral and ethical practice in organizations
- Mr. Charles Wookey
-
97. SMART work: implementing better work design
- Prof. Sharon Parker
- Covid-19: Impact and Responses
-
99. Planning and response to COVID-19: lessons from China and South-East Asia
- Prof. Annelies Wilder-Smith
-
100. The impact of COVID-19 on higher education
- Dr. Wendy M. Purcell
-
101. The impact of Covid-19 on psychological safety in the workplace
- Prof. Amy C. Edmondson
-
102. The impact of Covid-19 on cybersecurity and data privacy
- Mr. Claudiu Popa
-
103. The impact of Covid-19 on organizations
- Prof. Paul J. H. Schoemaker
-
104. The impact of Covid-19 on tourism
- Mr. Robin Barker
-
105. Insolvencies in the era of COVID-19
- Dr. Keith Pond
-
106. Government response and economic impact during COVID-19
- Prof. James K. Galbraith
-
107. International aid for developing countries in the age of Covid-19
- Prof. Anne Krueger
-
108. The impact of COVID-19 on international trade
- Dr. Mona Chung
Topics Covered
- COVID-19
- SARS
- Community compliance
- Healthcare infrastructure
- Epidemic preparedness
- Public health
- Community buy-in
- History of epidemic
- Trust
- Contact tracing
- Reporting
- Disease burden
- Communication strategy
- Social media
- Top-down approach
- Leadership
- Herd immunity
- WHO
Biography
Annelies Wilder-Smith is Professor of Emerging Infectious Diseases at the London School of Hygiene and Tropical Medicine, and visiting Professor at the Lee Kong Chian School of Medicine, Singapore. She also serves as Consultant to the Initiative of Vaccine Research at the World Health Organization, Geneva, Switzerland. She is the Past President of the International Society of Travel Medicine (ISTM), and Past-President of the Asia Pacific Society of Travel Medicine.
Her special research interests include travel health, vaccine preventable and emerging infectious diseases, in particular dengue, Zika, yellow fever, chikgununya, influenza and meningococcal disease. With a career spanning almost three decades, she has led and co-led various clinical trials, published more than 280 scientific papers, edited and co-edited textbooks and travel medicine books, served on various editorial boards and scientific committees, including being editorial consultant to The Lancet. Her awards include the Myrone Levine Vaccinology Prize, the Honor Group Award for exemplary leadership and coordination in determining and communicating global yellow fever risk presented at the CDC Award Ceremony, the Mercator Professorship award by the German Research Foundation and the Ashdown Oration Award by the Australian College of Travel Medicine. She is the Principal Investigator of an EU funded international consortium called “ZikaPLAN,” and recently completed another 4 year research project on dengue, also funded by the European Commission.
Professor Wilder Smith obtained her MD from the University of Heidelberg, Germany, in 1987, her Master in International Health from Curtin University in Australia, and her PhD from the University of Amsterdam, The Netherlands, in 2003. The topic of her PhD was on “W135 meningococcal disease in Hajj pilgrims”. Over the past 15 years she has developed and taught courses in global health, communicable diseases and travel medicine both in Singapore and beyond. She worked and lived in the Asia Pacific region for more than 18 years (China, Nepal, Papua New Guinea and since 1998 in Singapore). From 2011-2012, she was the Director of Master Programme in International Health at the Institute of Public Health, University of Heidelberg, Germany.
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Wilder-Smith, A. (2023, May 16). Planning and response to COVID-19: lessons from China and South-East Asia [Audio file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 1, 2025, from https://doi.org/10.69645/MHJT3352.Export Citation (RIS)
Publication History
- Published on May 16, 2023
Financial Disclosures
- Prof. Annelies Wilder-Smith has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Planning and response to COVID-19: lessons from China and South-East Asia
A selection of talks on Infectious Diseases
Transcript
Quiz
Disclaimer: This quiz is intended for learning assessment purposes only and does not grant any certification or credit.
If you are interested in getting a certificate for watching the talk, follow the instructions in this talk's Accreditation Information (where available.)